Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry.
Paulus Stefan RommerKerstin EichstädtDavid EllenbergerPeter FlacheneckerTim FriedeJudith HaasChristoph KleinschnitzDieter PöhlauOtto RienhoffAlexander StahmannUwe Klaus ZettlPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2018)
Whereas treatment for spasticity and depression is common in our cohort, sexual dysfunction, dysphagia, cognitive dysfunction, and fatigue are treated to a far lesser extent. The need for psychological support, physical, and occupational therapy has to be recognized as neuropsychological symptoms have a great impact on retirement at an early stage. Overall symptomatic treatment rates for the most common symptoms have increased over the last years (p < 0.001).